Julianne Byrne
YOU?
Author Swipe
View article: Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors – a genome-wide association study: results from PanCareLIFE
Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors – a genome-wide association study: results from PanCareLIFE Open
View article: Implementation of the Short-Form 36 (SF-36) in childhood cancer survivors: An analysis on measurement properties across 5 European countries
Implementation of the Short-Form 36 (SF-36) in childhood cancer survivors: An analysis on measurement properties across 5 European countries Open
Purpose The Short Form-36 (SF-36) is widely used in many research contexts and cultures to assess health-related quality of life (HRQOL). We investigated the measurement properties of the SF-36 in a large cohort study among childhood cance…
View article: Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study
Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study Open
View article: Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study
Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study Open
View article: The impact of the temporal sequence of cranial radiotherapy and platin‐based chemotherapy on hearing impairment in pediatric and adolescent <scp>CNS</scp> and <scp>head‐and‐neck</scp> cancer patients: A report from the <scp>PanCareLIFE</scp> consortium
The impact of the temporal sequence of cranial radiotherapy and platin‐based chemotherapy on hearing impairment in pediatric and adolescent <span>CNS</span> and <span>head‐and‐neck</span> cancer patients: A report from the <span>PanCareLIFE</span> consortium Open
The impact of the temporal sequence by which cranial radiotherapy (CRT) and platin‐based chemotherapy (PCth) are administered on sensorineural hearing loss (SNHL) in pediatric and adolescent central nervous system (CNS) and head‐and‐neck (…
View article: Auditory Complications among Childhood Cancer Survivors and Health-related Quality of Life: A PanCareLIFE study
Auditory Complications among Childhood Cancer Survivors and Health-related Quality of Life: A PanCareLIFE study Open
Auditory complications are potential side effects from childhood cancer treatment. Yet, limited evidence exists about the impact of auditory complications—particularly tinnitus—on health-related quality of life (HRQoL) among childhood canc…
View article: Risk of subsequent primary lymphoma in a cohort of 69,460 five‐year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study
Risk of subsequent primary lymphoma in a cohort of 69,460 five‐year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study Open
Background Survivors of Hodgkin lymphoma (HL) are at risk of developing non‐Hodgkin lymphoma (NHL) after treatment; however, the risks of developing subsequent primary lymphomas (SPLs), including HL and NHL, after different types of childh…
View article: Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study Open
View article: Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study Open
Background: Survivors of childhood cancer are at risk of subsequent primary malignant neoplasms (SPNs), but the risk for rarer types of SPNs, such as oral cancer, is uncertain. Previous studies included few oral SPNs, hence large-scale coh…
View article: Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort
Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort Open
Background Data on late mortality from pediatric germ cell tumors (GCTs) are limited to small case series. Our population‐based study aimed to investigate excess risk of death in survivors of GCT in childhood and adolescence, whether long‐…
View article: Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study
Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study Open
PURPOSE Heart failure (HF) is a potentially life-threatening complication of treatment for childhood cancer. We evaluated the risk and risk factors for HF in a large European study of long-term survivors. Little is known of the effects of …
View article: Impact of era of diagnosis on cause‐specific late mortality among 77 423 five‐year European survivors of childhood and adolescent cancer: The <scp>PanCareSurFup</scp> consortium
Impact of era of diagnosis on cause‐specific late mortality among 77 423 five‐year European survivors of childhood and adolescent cancer: The <span>PanCareSurFup</span> consortium Open
Late mortality of European 5‐year survivors of childhood or adolescent cancer has dropped over the last 60 years, but excess mortality persists. There is little information concerning secular trends in cause‐specific mortality among older …
View article: Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study Open
Background: Female childhood cancer survivors (CCSs) carry a risk of therapy-related gonadal dysfunction. Alkylating agents (AA) are well-established risk factors, yet inter-individual variability in ovarian function is observed. Polymorph…
View article: TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study Open
View article: Managing a Pan-European Consortium on Late Effects among Long-Term Survivors of Childhood and Adolescent Cancer—The PanCareLIFE Project
Managing a Pan-European Consortium on Late Effects among Long-Term Survivors of Childhood and Adolescent Cancer—The PanCareLIFE Project Open
PanCareLIFE brought together European partners and is the largest study to have evaluated the issues of fertility impairment, hearing loss, and health-related quality of life in survivors of childhood and adolescent cancer. Successful deli…
View article: Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group Open
View article: Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group Open
View article: Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group Open
View article: Health-Related Quality of Life in European Childhood Cancer Survivors: Protocol for a Study Within PanCareLIFE
Health-Related Quality of Life in European Childhood Cancer Survivors: Protocol for a Study Within PanCareLIFE Open
Background Survival after childhood cancer has improved to more than 80% during the last few years, leading to an increased number of childhood cancer survivors. Cancer itself, or its treatment, may cause chronic health conditions, includi…
View article: Possible modification of <i>BRSK1</i> on the risk of alkylating chemotherapy-related reduced ovarian function
Possible modification of <i>BRSK1</i> on the risk of alkylating chemotherapy-related reduced ovarian function Open
STUDY QUESTION Do genetic variations in the DNA damage response pathway modify the adverse effect of alkylating agents on ovarian function in female childhood cancer survivors (CCS)? SUMMARY ANSWER Female CCS carrying a common BR serine/th…
View article: Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study
Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study Open
Background Survivors of childhood cancer are at risk of subsequent primary neoplasms (SPNs), but the risk of developing specific digestive SPNs beyond age 40 years remains uncertain. We investigated risks of specific digestive SPNs within …
View article: Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study Open
View article: Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset Open
View article: Health-Related Quality of Life in European Childhood Cancer Survivors: Protocol for a Study Within PanCareLIFE (Preprint)
Health-Related Quality of Life in European Childhood Cancer Survivors: Protocol for a Study Within PanCareLIFE (Preprint) Open
BACKGROUND Survival after childhood cancer has improved to more than 80% during the last few years, leading to an increased number of childhood cancer survivors. Cancer itself, or its treatment, may cause chronic health conditions, includ…
View article: Fertility education for adolescent cancer patients: Gaps in current clinical practice in Europe
Fertility education for adolescent cancer patients: Gaps in current clinical practice in Europe Open
Objective As adolescent cancer patients may suffer from infertility following treatment, fertility counselling is essential. Our aim was to explore the current situation in four European countries in terms of (I) education about the risk f…
View article: PCA results for six kava (Piper methysticum) samples collected and analyzed by GC×GC-qMS/FID
PCA results for six kava (Piper methysticum) samples collected and analyzed by GC×GC-qMS/FID Open
Data includes the data processing file (The Unscrambler X version 10.4 (CAMO Software, Oslo, Norway)) and final results of the analysis.
View article: Methods for sampling, acquisition and data processing of six kava (Piper methysticum) samples collected and analyzed by GC×GC-qMS/FID
Methods for sampling, acquisition and data processing of six kava (Piper methysticum) samples collected and analyzed by GC×GC-qMS/FID Open
Data includes all method parameters and files from instrument and software.
View article: Volatile organic compound data files from six kava (Piper methysticum) samples collected and analyzed by GC×GC-qMS/FID
Volatile organic compound data files from six kava (Piper methysticum) samples collected and analyzed by GC×GC-qMS/FID Open
Volatile organic compound raw data files (*.cdf) from six kava (Piper methysticum) samples collected and analyzed by comprehensive two-dimensional gas chromatography – quadrupole mass spectrometry/flame ionization detection (GC×GC-qMS/FID)…
View article: Sample reports and alignment of six kava (Piper methysticum) samples collected and analyzed by GC×GC-qMS/FID
Sample reports and alignment of six kava (Piper methysticum) samples collected and analyzed by GC×GC-qMS/FID Open
Alignment excel spreadsheet, sample summary reports generated from sequencing FID sample files. Kava samples: Sample 1: Tikaram’s (Tonga) Sample 2: Unknown (Tonga) Sample 3: Tikaram’s (Vanuatu) Sample 4: Mai (Fiji) Sample 5: Happy Warrior …
View article: SeqReport_Sample Summary Report_kava_sample6_FID.xls
SeqReport_Sample Summary Report_kava_sample6_FID.xls Open
Sample Summary Report from sequencing FID sample 6.